Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
IWM ETF Rises 0.3%, Outperforms Underlying Index

IWM ETF Rises 0.3%, Outperforms Underlying Index

Dow JonesDow Jones2026/09/04 20:36

This article was automatically generated using Dow Jones technology.

Shares of iShares Russell 2000 ETF advanced 0.3% to $296.01 Friday on what proved to be an overall unfavorable trading session for the U.S. stock market, with the S&P 500 Index falling 0.4% to 7,718.60.

This was the fund's third consecutive day of gains. The fund's underlying index, the Russell 2000 Index, rose 0.2%.

The ETF's shares closed 3.0% below the 52-week high of $305.18 seen on August 14, 2026.

Trading volume was 13,856,778, compared to the 65-day average trading volume of 22,735,523.

As of September 3, the fund's net asset value totaled $295.27 per share.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 04, 2026 16:36 ET (20:36 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Twice thwarted in a week! Novartis (NVS.US) fails in phase III trial for blockbuster heart disease drug, stock plummets; Amgen (AMGN.US) dragged down as well

Swiss pharmaceutical giant Novartis has suffered another clinical trial setback—within one week, the company’s second major drug candidate has failed in a late-stage study. This latest disappointment concerns its potential blockbuster heart disease drug pelacarsen.

智通财经2026/09/07 07:31
Twice thwarted in a week! Novartis (NVS.US) fails in phase III trial for blockbuster heart disease drug, stock plummets; Amgen (AMGN.US) dragged down as well